Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media (NCT01588535) | Clinical Trial Compass
CompletedPhase 2
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
United States38 participantsStarted 2012-05
Plain-language summary
This study is to assess the reliability and validity of the FAECC scale to evaluate pain associated with acute otitis media in children aged 2 months to 5 years.
Who can participate
Age range2 Months – 4 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The patient has age in the interval 2 months ≤ age \< 5.00 years, signs and symptoms of AOM, and moderate to severe pain (current episode ≤ 2 weeks duration). Moderate to severe pain is defined as a score of \> or = 4 (on a scale of 0 - 10) for the FAECC scale as assessed by the primary assessor.
* The patient's parent/guardian must have read and signed the written informed consent prior to study participation.
* The patient is normally active and otherwise judged to be in good health on the basis of medical history and limited physical examination.
Exclusion Criteria:
* Patient has perforated tympanic membrane, history of a perforated tympanic membrane in the last 6 months, or if a perforated tympanic membrane could not be ruled out by speculum examination, impedance testing tympanometry, pneumatic otoscopy, or Valsalva maneuver. Patients who are subsequently diagnosed with a perforated membrane during treatment are to be discontinued immediately. Patients with tympanostomy tubes are not allowed.
* Patient has acute or chronic otitis externa.
* Patient has chronic otitis media (current episode ≥ 2 weeks).
* Patient has seborrheic dermatitis involving the affected external ear canal or pinna.
* Patient has received any otic topical or systemic antibiotic within 14 days prior to study entry (topical or systemic antibiotics for acne will be allowed on a chronic basis for subjects who have been on a stable dose for at least 14 days prior to entry).
* Pat…
What they're measuring
1
Consistency of primary assessor and caregiver FAECC scores using Pearson's correlation coefficient
Timeframe: up to 120 minutes after first dose and Day 4